{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:52:05Z","timestamp":1791503525698,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004348","name":"Region Stockholm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.josat.2024.209508","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T20:05:47Z","timestamp":1725653147000},"page":"209508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["At the tipping point: Patient experiences of addiction to benzodiazepines and motivation to seek treatment"],"prefix":"10.1016","volume":"167","author":[{"given":"Sofia","family":"Burmester","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Franck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde Hedlund","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Westman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.josat.2024.209508_bb0005","first-page":"217","article-title":"The slippery slope of flubromazolam: Experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum","volume":"34","author":"Andersson","year":"2017","journal-title":"Nordisk Alkohol Nark"},{"issue":"7","key":"10.1016\/j.josat.2024.209508_bb0010","first-page":"1200","article-title":"First benzodiazepine prescriptions: Qualitative study of patients\u2019 perspectives","volume":"53","author":"Anthierens","year":"2007","journal-title":"Canadian Family Physician"},{"issue":"6","key":"10.1016\/j.josat.2024.209508_bb0015","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/fampra\/13.6.491","article-title":"The long-term use of benzodiazepines: Patients\u2019 views, accounts and experiences","volume":"13","author":"Barter","year":"1996","journal-title":"Family Practice"},{"key":"10.1016\/j.josat.2024.209508_bb0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.drugalcdep.2015.01.031","article-title":"Probability and predictors of treatment-seeking for substance use disorders in the U.S","volume":"149","author":"Blanco","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.josat.2024.209508_bb0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qualitative Research in Psychology"},{"key":"10.1016\/j.josat.2024.209508_bb0030","series-title":"Thematic analysis: A practical guide","author":"Braun","year":"2022"},{"issue":"8","key":"10.1016\/j.josat.2024.209508_bb0035","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1080\/01634372.2014.901470","article-title":"Perceptions of benzodiazepine dependence among women age 65 and older","volume":"57","author":"Canham","year":"2014","journal-title":"Journal of Gerontological Social Work"},{"issue":"6","key":"10.1016\/j.josat.2024.209508_bb0040","first-page":"470","article-title":"Mother's little helper? Contrasting accounts of benzodiazepine and methadone use among drug-dependent parents in the UK","volume":"21","author":"Chandler","year":"2014","journal-title":"Drugs (Abingdon Engl)"},{"issue":"8","key":"10.1016\/j.josat.2024.209508_bb0045","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s11606-007-0205-5","article-title":"Older patient perspectives on long-term anxiolytic benzodiazepine use and discontinuation: A qualitative study","volume":"22","author":"Cook","year":"2007","journal-title":"Journal of General Internal Medicine"},{"issue":"8","key":"10.1016\/j.josat.2024.209508_bb0050","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1037\/adb0000318","article-title":"Motivational interviewing, enhancement, and brief interventions over the last decade: A review of reviews of efficacy and effectiveness","volume":"31","author":"DiClemente","year":"2017","journal-title":"Psychology of Addictive Behaviors"},{"issue":"6","key":"10.1016\/j.josat.2024.209508_bb0055","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.0269-4727.2003.00523.x","article-title":"Managing insomnia in the elderly - What prevents us using non-drug options?","volume":"28","author":"Dollman","year":"2003","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"1","key":"10.1016\/j.josat.2024.209508_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0306-4603(00)00090-3","article-title":"Sources of motivation for abstinence: A replication analysis of the reasons for quitting questionnaire","volume":"26","author":"Downey","year":"2001","journal-title":"Addictive Behaviors"},{"issue":"10","key":"10.1016\/j.josat.2024.209508_bb0065","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1176\/appi.ajp.2010.09081132","article-title":"The role of a prescription in anxiety medication use, abuse, and dependence","volume":"167","author":"Fenton","year":"2010","journal-title":"The American Journal of Psychiatry"},{"issue":"13","key":"10.1016\/j.josat.2024.209508_bb0070","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1177\/1049732317728053","article-title":"Stories of hell and healing: Internet users\u2019 construction of benzodiazepine distress and withdrawal","volume":"27","author":"Fixsen","year":"2017","journal-title":"Qualitative Health Research"},{"issue":"2","key":"10.1016\/j.josat.2024.209508_bb0075","first-page":"155","article-title":"Self-determination theory: Intrinsic motivation and behavioral change","volume":"44","author":"Flannery","year":"2017","journal-title":"Oncology Nursing Forum"},{"issue":"8","key":"10.1016\/j.josat.2024.209508_bb0080","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00228-023-03515-2","article-title":"Factors associated with long-term benzodiazepine and Z-drug use across the lifespan and 5-year temporal trajectories among incident users: A Swedish nationwide register-based study","volume":"79","author":"Isomura","year":"2023","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"11","key":"10.1016\/j.josat.2024.209508_bb0085","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archpsyc.58.11.1065","article-title":"Patterns and predictors of treatment seeking after onset of a substance use disorder","volume":"58","author":"Kessler","year":"2001","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.josat.2024.209508_bb0090","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12888-015-0493-y","article-title":"High-dose benzodiazepine dependence: A qualitative study of patients\u2019 perception on cessation and withdrawal","volume":"15","author":"Liebrenz","year":"2015","journal-title":"BMC Psychiatry"},{"issue":"11","key":"10.1016\/j.josat.2024.209508_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142057","article-title":"High-dose benzodiazepine dependence: A qualitative study of patients\u2019 perceptions on initiation, reasons for use, and obtainment","volume":"10","author":"Liebrenz","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.josat.2024.209508_bb0100","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/hex.13392","article-title":"\u2018I just thought that it was such an impossible thing\u2019: A qualitative study of barriers and facilitators to discontinuing long-term use of benzodiazepine receptor agonists using the Theoretical Domains Framework","volume":"25","author":"Lynch","year":"2022","journal-title":"Health Expectations"},{"issue":"13","key":"10.1016\/j.josat.2024.209508_bb0105","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1177\/1049732315617444","article-title":"Sample size in qualitative interview studies: Guided by information power","volume":"26","author":"Malterud","year":"2016","journal-title":"Qualitative Health Research"},{"key":"10.1016\/j.josat.2024.209508_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1129447","article-title":"Prevalence and correlates of the misuse of z-drugs and benzodiazepines in the National Survey on Drug Use and Health","volume":"14","author":"McHugh","year":"2023","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.josat.2024.209508_bb0115","author":"National Board of Health and Welfare","year":"2021"},{"key":"10.1016\/j.josat.2024.209508_bb1005","unstructured":"National Institute for Health and Care Excellence (2004). Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia: Technology appraisal guidance Retrieved January 18, 2024, from. www.nice.org.uk\/guidance\/ta77."},{"key":"10.1016\/j.josat.2024.209508_bb1000","unstructured":"National Institute for Health and Care Excellence (2014). Anxiety disorders: Quality standard (QS53) Retrieved January 18, 2024, from. www.nice.org.uk\/guidance\/qs53."},{"issue":"9","key":"10.1016\/j.josat.2024.209508_bb0130","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","article-title":"Standards for reporting qualitative research: A synthesis of recommendations","volume":"89","author":"O\u2019Brien","year":"2014","journal-title":"Academic Medicine"},{"issue":"708","key":"10.1016\/j.josat.2024.209508_bb0135","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.3399\/BJGP.2020.1062","article-title":"Role of the prescriber in supporting patients to discontinue benzodiazepines: A qualitative study","volume":"71","author":"Oldenhof","year":"2021","journal-title":"The British Journal of General Practice"},{"issue":"5","key":"10.1016\/j.josat.2024.209508_bb0140","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.socscimed.2005.07.016","article-title":"Views of general practitioners and benzodiazepine users on benzodiazepines: A qualitative analysis","volume":"62","author":"Parr","year":"2006","journal-title":"Social Science & Medicine"},{"key":"10.1016\/j.josat.2024.209508_bb0145","series-title":"Qualitative research and evaluation methods","author":"Patton","year":"2002"},{"issue":"1","key":"10.1016\/j.josat.2024.209508_bb0150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mcna.2021.08.012","article-title":"Benzodiazepines and related sedatives","volume":"106","author":"Peng","year":"2022","journal-title":"The Medical Clinics of North America"},{"key":"10.1016\/j.josat.2024.209508_bb0155","article-title":"Why do those with long-term substance use disorders stop abusing substances? A qualitative study","volume":"12","author":"Pettersen","year":"2018","journal-title":"Substance Abuse"},{"issue":"4","key":"10.1016\/j.josat.2024.209508_bb0160","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/ijnp\/pyz007","article-title":"An insight into Z-drug abuse and dependence: An examination of reports to the European medicines agency database of suspected adverse drug reactions","volume":"22","author":"Schifano","year":"2019","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.josat.2024.209508_bb0165","series-title":"Principles of addiction: Comprehensive addictive behaviors and disorders","first-page":"61","article-title":"The biopsychosocial model of addiction","volume":"Vol. 1","author":"Skewes","year":"2013"},{"key":"10.1016\/j.josat.2024.209508_bb0170","author":"The Swedish Council for Information on Alcohol and Other Drugs"},{"key":"10.1016\/j.josat.2024.209508_bb0175","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: A systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"issue":"7","key":"10.1016\/j.josat.2024.209508_bb0180","first-page":"506","article-title":"A circle of silence: The attitudes of patients older than 65 years of age to ceasing long-term sleeping tablets","volume":"45","author":"Williams","year":"2016","journal-title":"Australian Family Physician"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924002200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924002200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T06:14:24Z","timestamp":1730614464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875924002200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":36,"alternative-id":["S2949875924002200"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2024.209508","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"At the tipping point: Patient experiences of addiction to benzodiazepines and motivation to seek treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2024.209508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209508"}}